Seitz M - Search Results

1

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.

Villiger PM, Adler S, Kuchen S, Wermelinger F, Dan D, Fiege V, Bütikofer L, Seitz M, Reichenbach S. Villiger PM, et al. Among authors: seitz m. Lancet. 2016 May 7;387(10031):1921-7. doi: 10.1016/S0140-6736(16)00560-2. Epub 2016 Mar 4. Lancet. 2016. PMID: 26952547 Clinical Trial.

2

Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series.

Seitz M, Reichenbach S, Bonel HM, Adler S, Wermelinger F, Villiger PM. Seitz M, et al. Swiss Med Wkly. 2011 Jan 17;141:w13156. doi: 10.4414/smw.2011.13156. eCollection 2011. Swiss Med Wkly. 2011. PMID: 21243547 Free article.

3

Magnetic resonance angiography in giant cell arteritis: results of a randomized controlled trial of tocilizumab in giant cell arteritis.

Reichenbach S, Adler S, Bonel H, Cullmann JL, Kuchen S, Bütikofer L, Seitz M, Villiger PM. Reichenbach S, et al. Among authors: seitz m. Rheumatology (Oxford). 2018 Jun 1;57(6):982-986. doi: 10.1093/rheumatology/key015. Rheumatology (Oxford). 2018. PMID: 29529280 Clinical Trial.

4

Immuno-monitoring reveals an extended subclinical disease activity in tocilizumab-treated giant cell arteritis.

Gloor AD, Yerly D, Adler S, Reichenbach S, Kuchen S, Seitz M, Villiger PM. Gloor AD, et al. Among authors: seitz m. Rheumatology (Oxford). 2018 Oct 1;57(10):1795-1801. doi: 10.1093/rheumatology/key158. Rheumatology (Oxford). 2018. PMID: 29961816 Free article. Clinical Trial.

5

The gouty spine: old guy-new tricks.

Adler S, Seitz M. Adler S, et al. Among authors: seitz m. Rheumatology (Oxford). 2017 Dec 1;56(12):2243-2245. doi: 10.1093/rheumatology/kex325. Rheumatology (Oxford). 2017. PMID: 28968912 No abstract available.

6

Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.

Seitz M, Zwicker M, Villiger PM. Seitz M, et al. J Rheumatol. 2003 Jan;30(1):28-35. J Rheumatol. 2003. PMID: 12508386

7

Hepatoprotective effect of tumour necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study.

Seitz M, Reichenbach S, Möller B, Zwahlen M, Villiger PM, Dufour JF. Seitz M, et al. Ann Rheum Dis. 2010 Jun;69(6):1148-50. doi: 10.1136/ard.2009.116194. Epub 2009 Oct 22. Ann Rheum Dis. 2010. PMID: 19854710

8

The complex clinical picture of side effects to biologicals.

Hausmann OV, Seitz M, Villiger PM, Pichler WJ. Hausmann OV, et al. Among authors: seitz m. Med Clin North Am. 2010 Jul;94(4):791-804, xi-ii. doi: 10.1016/j.mcna.2010.03.001. Med Clin North Am. 2010. PMID: 20609863 Review.

9

The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients.

Seitz M, Wirthmüller U, Möller B, Villiger PM. Seitz M, et al. Rheumatology (Oxford). 2007 Jan;46(1):93-6. doi: 10.1093/rheumatology/kel175. Epub 2006 May 23. Rheumatology (Oxford). 2007. PMID: 16720636

10

Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.

Aeberli D, Seitz M, Jüni P, Villiger PM. Aeberli D, et al. Among authors: seitz m. Rheumatology (Oxford). 2005 Feb;44(2):172-5. doi: 10.1093/rheumatology/keh437. Epub 2004 Oct 27. Rheumatology (Oxford). 2005. PMID: 15509629

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

452 results

Search Page

Filters